The Company continues to prosecute additional patent applications in the United States and abroad related to its regenerative technologies and SkinTE®. (businesswire.com)
Analyst Ratings PTE Price Target: 421.72% upside
Market Cap of only 34.265M
Total revenues were $3.34 million in Q3:20 compared to $1. 40 million in Q3:19
SkinTE revenues were $1.16 million in Q3:20 compared to $0.84 million in Q3:19
Contract services revenues were $2.18 million in Q3:20 and includes $1.75 million from COVID-19 testing
The indicators signal Buy recommendations on most timeframes!
If you are interested to test some amazing BUY and SELL INDICATORS that i use, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
My Best Stock Picks: https://www.patreon.com/tradingindicators